Frank L. Custers

Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life

Maureen Rutten‐van Mölken, Frank L. Custers, Eddy van Doorslaer et al. · European Respiratory Journal · 1995 · 193 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study

Wieneke A. Buikhuisen, Jacobus A. Burgers, Andrew Vincent et al. · The Lancet Oncology · 2013 · 99 citations

Medicine, Oncology, Chemotherapy +10

Thalidomide in patients with malignant pleural mesothelioma

Willem Boogerd, Otilia Dalesio, A. Haringhuizen et al. · Lung Cancer · 2004 · 93 citations

Medicine, Oncology, Chemotherapy +8

Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease

J.A. van Noord, J.J. Smeets, Frank L. Custers et al. · European Respiratory Journal · 2002 · 91 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial

Dave Singh, Christopher E. Brightling, Klaus F. Rabe et al. · The Lancet Respiratory Medicine · 2024 · 64 citations · Full text

Medicine, Internal Medicine, Pharmacology +10